Mouse Anti-CUX1 Recombinant Antibody (2A10) (V2LY-0125-LY550)

Supper, E., Rudat, S., Iyer, V., Droop, A., Wong, K., Spinella, J. F., ... & Wong, C. C. (2021). Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia. Nature communications, 12(1), 1-20.

Yang, F., Hu, A., Guo, Y., Wang, J., Li, D., Wang, X., ... & Tong, Q. (2021). p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation. Molecular cancer, 20(1), 1-19.

Yu, L., Zhong, L., Xiong, L., Dan, W., Li, J., Ye, J., ... & Liu, B. (2020). Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 CUX1 promotes cell proliferation and inhibits cell differentiation in APL. Life Sciences, 242, 117229.

Slowikowski, K., Nguyen, H. N., Noss, E. H., Simmons, D. P., Mizoguchi, F., Watts, G. F., ... & Raychaudhuri, S. (2020). CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts. Proceedings of the National Academy of Sciences, 117(10), 5532-5541.

Aly, M., Ramdzan, Z. M., Nagata, Y., Balasubramanian, S. K., Hosono, N., Makishima, H., ... & Maciejewski, J. P. (2019). Distinct clinical and biological implications of CUX1 in myeloid neoplasms. Blood advances, 3(14), 2164-2178.

Li, H., Yang, F., Hu, A., Wang, X., Fang, E., Chen, Y., ... & Tong, Q. (2019). Therapeutic targeting of circ‐CUX 1/EWSR 1/MAZ axis inhibits glycolysis and neuroblastoma progression. EMBO molecular medicine, 11(12), e10835.

Wu, X., Feng, F., Yang, C., Zhang, M., Cheng, Y., Zhao, Y., ... & Heng, X. (2019). Upregulated expression of CUX1 correlates with poor prognosis in glioma patients: a bioinformatic analysis. Journal of Molecular Neuroscience, 69(4), 527-537.

Zhang, M., Wang, Q., Ding, Y., Wang, G., Chu, Y., He, X., ... & Lu, K. (2018). CUX1-ALK, a novel ALK rearrangement that responds to crizotinib in non–small cell lung cancer. Journal of Thoracic Oncology, 13(11), 1792-1797.

Kaur, S., Ramdzan, Z. M., Guiot, M. C., Li, L., Leduy, L., Ramotar, D., ... & Nepveu, A. (2018). CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide. Neuro-oncology, 20(4), 484-493.

Xu, H., He, J. H., Xu, S. J., Xie, S. J., Ma, L. M., Zhang, Y., ... & Qu, L. H. (2018). A group of tissue‐specific microRNAs contribute to the silencing of CUX1 in different cell lineages during development. Journal of cellular biochemistry, 119(7), 6238-6248.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols